Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Same-day discharge surgery for robot-assisted radical prostatectomy in the era of ERAS and prehabilitation pathways: a contemporary, comparative, feasibility study.

Ploussard G, Almeras C, Beauval JB, Gautier JR, Loison G, Salin A, Tollon C.

World J Urol. 2020 Feb 17. doi: 10.1007/s00345-020-03119-w. [Epub ahead of print]

PMID:
32065277
2.

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.

Ploussard G, Beauval JB, Renard-Penna R, Lesourd M, Manceau C, Almeras C, Gautier JR, Loison G, Portalez D, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

J Clin Med. 2020 Jan 15;9(1). pii: E225. doi: 10.3390/jcm9010225.

3.

Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.

Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G.

Urol Oncol. 2020 Jan 13. pii: S1078-1439(19)30505-8. doi: 10.1016/j.urolonc.2019.12.018. [Epub ahead of print]

PMID:
31948932
4.

Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

Urology. 2019 Dec 30. pii: S0090-4295(19)31124-0. doi: 10.1016/j.urology.2019.10.039. [Epub ahead of print]

PMID:
31899229
5.

Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.

Ploussard G, Manceau C, Beauval JB, Lesourd M, Almeras C, Gautier JR, Loison G, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

World J Urol. 2019 Dec 14. doi: 10.1007/s00345-019-03053-6. [Epub ahead of print]

PMID:
31838560
6.

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.

Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2019 Oct 14. doi: 10.1007/s00345-019-02973-7. [Epub ahead of print]

PMID:
31612251
7.

Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

J Urol. 2019 Dec;202(6):1182-1187. doi: 10.1097/JU.0000000000000418. Epub 2019 Jun 27.

PMID:
31246548
8.

Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2019 Jun 13. doi: 10.1007/s00345-019-02848-x. [Epub ahead of print]

PMID:
31197523
9.

Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature.

Ploussard G, Almeras C, Briganti A, Giannarini G, Hennequin C, Ost P, Renard-Penna R, Salin A, Lebret T, Villers A, Soulié M, de la Taille A, Flamand V.

J Urol. 2015 Oct;194(4):983-8. doi: 10.1016/j.juro.2015.04.103. Epub 2015 May 9. Review.

PMID:
25963190
10.

Single graft loss in dual renal transplant recipients: impact of graft placement on recipient outcomes.

Timsit MO, Rabant M, Snanoudj R, Cohen D, Salin A, Malek S, Rouach Y, Kreis H, Legendre C, Mejean A.

Transpl Int. 2011 Jan;24(1):51-7. doi: 10.1111/j.1432-2277.2010.01145.x.

11.

Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.

Descazeaud A, Peyromaure M, Salin A, Amsellem-Ouazana D, Flam T, Viellefond A, Debré B, Zerbib M.

Eur Urol. 2008 Feb;53(2):355-61. Epub 2007 Jun 26.

PMID:
17611015
12.

[Prospective evaluation of the effects of a practical introduction to urology session on the recruitment of urology intern in Paris: final results].

Pignot G, Beley S, Larré S, Dubosq F, Salin A, Albouy B, Simon P, Rolland E, Chartier-Kastler E, Richard F, Rouprêt M.

Prog Urol. 2007 Apr;17(2):240-4. French.

PMID:
17489326
13.

Identification of risk factors for voiding dysfunction following TVT placement.

Salin A, Conquy S, Elie C, Touboul C, Parra J, Zerbib M, Debré B, Amsellem-Ouazana D.

Eur Urol. 2007 Mar;51(3):782-7; discussion 787. Epub 2006 Nov 3.

PMID:
17098355

Supplemental Content

Loading ...
Support Center